◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

ISE Chemicals Corporation (4107)

Name: ISE Chemicals Corporation（4107）— 財務諸表の推移
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

公式財務諸表に基づく売上高、利益、キャッシュフローの推移。

Basic Materials · ウォール街（米国） · 最終更新: 2026-10-02

ISE Chemicals Corporation engages in the iodine and natural gas, and metallic compound businesses in Japan. It offers iodine products, such as ISEFLO, a prilled iodine; crude iodine; potassium, sodium, and cuprous iodide, as well as hydroiodic acid. The company also provides metallic compounds, including nickel chloride, cobalt chloride, cobalt hydroxide, and tricobalt tetraoxide; and extracts and supplies natural gas to gas companies and factories. Its products are used in medical, feed additives, disinfectants, and electronic component industries.

主要指標

時価総額: JPY 198 billion
売上高（2025-12-31 期末の会計年度）: JPY 39.3B
当期純利益: JPY 6.5B
売上総利益率: 31.6%
純利益率: 16.6%

インタラクティブチャートと全財務諸表を見る → バリュエーションモデル（DCF）→

年次損益計算書

損益計算書	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
売上高合計	JPY 39.3B	JPY 33.3B	JPY 26.4B	JPY 25.6B	—
売上総利益	JPY 12.4B	JPY 10.1B	JPY 7.4B	JPY 5.7B	—
営業利益（EBIT）	JPY 9.5B	JPY 7.7B	JPY 5.3B	JPY 3.8B	—
当期純利益	JPY 6.5B	JPY 5.1B	JPY 3.7B	JPY 2.6B	—

出典: 企業の公開資料（SEC）。数値をご利用の前に SEC EDGAR でご確認ください。

貸借対照表、キャッシュフロー計算書、四半期データおよび全財務比率は 4107 のインタラクティブ・ビューアーでご覧いただけます。 /companies/us/4107

類似企業

本サイトの情報は教育および情報提供のみを目的としており、投資助言ではありません。目標株価や投資判断は掲載していません。

English version →全銘柄

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.